The highest diagnostic yield for monogenic glomerular disorders (8.7%) and high-risk APOL1 genotypes (19%) was observed in patients with FSGS, as expected given the rarity of monogenic forms of non-FSGS glomerulopathies. Here, APOL1 is linked to focal segmental glomerulosclerosis.